Abstract
The hitherto unreported 2-aryl-10H-thiochromeno[3,2-b][1,4]oxathiin-10-one derivatives are obtained in a single pot from 4-hydroxydithiocoumarins, arylacetylenes and dimethyl sulfoxide in the presence of 10 mol% CuI and K2CO3in an oil bath at 70 °C. The novelties of the present protocol are (i) selective C-H functionalization at the C-3 position of 4-hydroxydithiocoumarin, (ii) regioselective hydrothiolation with arylacetylenes and (iii) concomitant cyclisation. The major advantages are mild reaction conditions, broad substrate scope and good yield. Among the synthesized compounds, the following five compounds3aa,3bd,3ec,3fa, and3fdshowed anticancer activity against a human breast cancer cell line (MCF-7) and a cervical cancer cell line (HeLa).
Cite
CITATION STYLE
Mondal, S., Yashmin, S., Ali, R., Soundaram, R., Ghosh, S. S., & Khan, A. T. (2021). Synthesis of biologically active fused 1,4-oxathiin derivatives from 4-hydroxydithiocoumarins, arylacetylenes and dimethyl sulfoxide by Cu(i)-catalyzed C-H functionalization and cross-dehydrogenative C-S coupling reactions. Organic and Biomolecular Chemistry, 19(26), 5818–5826. https://doi.org/10.1039/d1ob00846c
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.